Evaluating a frontostriatal working-memory updating-training paradigm in Parkinson’s disease: the iPARK trial, a double-blinded randomized controlled trial

Abstract Background Cognitive decline and dementia are common in Parkinson’s disease (PD). Cognitive deficits have been linked to the depletion of dopamine in the nigrostriatal pathway, but pharmacological treatments for PD have little evidence of improving or delaying cognitive decline. Therefore,...

Full description

Bibliographic Details
Main Authors: Magdalena Eriksson Domellöf, Lois Walton, Carl-Johan Boraxbekk, David Bäckström, Maria Josefsson, Lars Forsgren, Anna Stigsdotter Neely
Format: Article
Language:English
Published: BMC 2020-09-01
Series:BMC Neurology
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12883-020-01893-z